BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 31264431)

  • 1. Advances in Acute Myeloid Leukemia Genomics, Where Do We Stand in 2018?
    Madanat YF; Kalaycio ME; Nazha A
    Acta Med Acad; 2019 Apr; 48(1):35-44. PubMed ID: 31264431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomics of Acute Myeloid Leukemia Diagnosis and Pathways.
    Bullinger L; Döhner K; Döhner H
    J Clin Oncol; 2017 Mar; 35(9):934-946. PubMed ID: 28297624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomics-based Approach and Prognostic Stratification Significance of Gene Mutations in Intermediate-risk Acute Myeloid Leukemia.
    Wang BH; Li YH; Yu L
    Chin Med J (Engl); 2015 Sep; 128(17):2395-403. PubMed ID: 26315090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next generation sequencing of acute myeloid leukemia: influencing prognosis.
    Ilyas AM; Ahmad S; Faheem M; Naseer MI; Kumosani TA; Al-Qahtani MH; Gari M; Ahmed F
    BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S5. PubMed ID: 25924101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.
    Yang F; Anekpuritanang T; Press RD
    Mol Diagn Ther; 2020 Feb; 24(1):1-13. PubMed ID: 31848884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
    Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
    Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating genomics into prognostic models for AML.
    Sanchez M; Levine RL; Rampal R
    Semin Hematol; 2014 Oct; 51(4):298-305. PubMed ID: 25311742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.
    Kohlmann A; Bacher U; Schnittger S; Haferlach T
    Leuk Lymphoma; 2014 Aug; 55(8):1725-34. PubMed ID: 24144312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational profiling of acute myeloid leukemia with normal cytogenetics in Brazilian patients: the value of next-generation sequencing for genomic classification.
    de Noronha TR; Mitne-Neto M; Chauffaille ML
    J Investig Med; 2017 Dec; 65(8):1155-1158. PubMed ID: 28923882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Landscape of Acute Myeloid Leukemia Interrogated by Next-generation Sequencing: A Large Cancer Center Experience.
    Hussaini MO; Mirza AS; Komrokji R; Lancet J; Padron E; Song J
    Cancer Genomics Proteomics; 2018; 15(2):121-126. PubMed ID: 29496691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
    Au CH; Wa A; Ho DN; Chan TL; Ma ES
    Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genes predictive of outcome and novel molecular classification schemes in adult acute myeloid leukemia.
    Verhaak RG; Valk PJ
    Cancer Treat Res; 2010; 145():67-83. PubMed ID: 20306246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia.
    Eisfeld AK; Mrózek K; Kohlschmidt J; Nicolet D; Orwick S; Walker CJ; Kroll KW; Blachly JS; Carroll AJ; Kolitz JE; Powell BL; Wang ES; Stone RM; de la Chapelle A; Byrd JC; Bloomfield CD
    Leukemia; 2017 Oct; 31(10):2211-2218. PubMed ID: 28321123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How I investigate acute myeloid leukemia.
    Narayanan D; Weinberg OK
    Int J Lab Hematol; 2020 Feb; 42(1):3-15. PubMed ID: 31820579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.
    Patel JL; Schumacher JA; Frizzell K; Sorrells S; Shen W; Clayton A; Jattani R; Kelley TW
    Leuk Res; 2017 May; 56():7-12. PubMed ID: 28152414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetics and genomics of acute myeloid leukemia.
    Snaith O; Poveda-Rogers C; Laczko D; Yang G; Morrissette JJD
    Best Pract Res Clin Haematol; 2024 Mar; 37(1):101533. PubMed ID: 38490763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myeloid leukaemia genomics.
    Medinger M; Passweg JR
    Br J Haematol; 2017 Nov; 179(4):530-542. PubMed ID: 28653397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational landscape of AML with normal cytogenetics: biological and clinical implications.
    Martelli MP; Sportoletti P; Tiacci E; Martelli MF; Falini B
    Blood Rev; 2013 Jan; 27(1):13-22. PubMed ID: 23261068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular Genetic Testing for Acute Myeloid Leukemia].
    Janečková V; Semerád L; Ježíšková I; Dvořáková D; Čulen M; Šustková Z; Mayer J; Ráčil Z
    Klin Onkol; 2016; 29(6):411-418. PubMed ID: 27951719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Malfeasance Mediating Myeloid Malignancies: The Genetics of Acute Myeloid Leukemia.
    King RL; Bagg A
    Methods Mol Biol; 2017; 1633():1-17. PubMed ID: 28735477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.